Acetylon Pharmaceuticals' Series B - II Round

Acetylon Pharmaceuticals raised a round of funding on June 29, 2011.

Acetylon Pharmaceuticals is a provider in the development of small molecule drugs targeting epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human disease…

Articles about Acetylon Pharmaceuticals' Series B - II Round: